[Modification of the metabolism by NAB 365 and therapeutic effect in bronchial asthma].
D000814:Aniline Compounds / Q000494:pharmacology / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D001786:Blood Glucose; D002241:Carbohydrates / Q000097:blood; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004734:Energy Metabolism / Q000187:drug effects*; D004983:Ethanolamines / Q000494:pharmacology / Q000627:therapeutic use*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005280:Fenoterol / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007328:Insulin / Q000097:blood; D011188:Potassium / Q000097:blood; D012964:Sodium / Q000097:blood; D014280:Triglycerides / Q000097:blood
D000814:Aniline Compounds; D001786:Blood Glucose; D002241:Carbohydrates; D004983:Ethanolamines; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D014280:Triglycerides; D005280:Fenoterol; D002784:Cholesterol; D012964:Sodium; D011188:Potassium
Stoffwechselbeeinflussung durch NAB 365 und therapeutische Wirkung bei Asthma bronchiale.